Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Express Scripts Holding Co    ESRX

Delayed Quote. Delayed  - 09/29 10:00:00 pm
69.84 USD   -1.54%
09/28 EXPRESS SCRIPTS : employees to vote on union representation
09/17 EXPRESS SCRIPTS : Launches Inflammatory Conditions Care Value Progra..
09/17 EXPRESS SCRIPTS : Launches Diabetes Care Value Program℠, Guara..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Express Scripts Earnings Surged 74%; Forecast Clears Lowered Hurdle

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/18/2013 | 11:18pm CEST
   By Jon Kamp 
 

Pharmacy-benefit manager Express Scripts Holding Co. (>> Express Scripts Holding Co) reported a 74% surge in fourth-quarter earnings, helped by a major acquisition, while forecasting 2013 earnings mostly ahead of a Wall Street target the company helped drag lower three months ago.

The St. Louis-based company--which manages drug-benefit programs for health plans and corporate customers--rattled analysts in November when it said their forecasts for 2013 looked too high. Express Scripts didn't release its own guidance at the time, but said a still-weak economy was weighing on the number of prescriptions it handles.

Monday's release finally included company guidance for adjusted earnings of $4.20 to $4.30 per share this year. The target is largely above the $4.20 forecast among analysts surveyed by Thomson Reuters, although Express Scripts' November warning caused analysts to trim the consensus forecast by about 30 cents since then.

This will mark the first full year of combined operations for Express Scripts and Medco Health Solutions, which created the largest pharmacy-benefit manager, or PBM, following April's $29.1 billion Medco acquisition.

"2012 was a monumental year for Express Scripts as we closed the acquisition of Medco and made significant progress integrating the two companies," George Paz, Express Scripts' chief executive, said in a press release.

The company plans to hold a conference call Tuesday morning. Its shares are up about 2.9% so far this year, through Friday's close, trailing a 6.6% gain in the Standard & Poor's 500 index.

The company reported fourth-quarter earnings of $504.1 million, or 61 cents a share, up from $290.4 million, or 59 cents a share, a year earlier. Excluding deal-related costs and other items, per-share earnings rose to $1.05 from 82 cents.

Revenue more than doubled to $27.41 billion from the year-earlier period, which was before the Medco deal.

Analysts surveyed by Thomson Reuters had forecast earnings of $1.04 a share on sales of $27.24 billion. Analysts are forecasting lower sales in coming quarters as health insurer UnitedHealth Group Inc. (>> UnitedHealth Group Inc.) brings in-house the PBM business it had outsourced to Medco.

Express Scripts saw adjusted claims--a measure that takes into account monthly prescriptions filled in retail pharmacies and 90-day fills through the company's mail-order business--rise 111% in the recent quarter to 410.8 million.

The company's full-year adjusted claims tally about matched its target by nearing 1.4 billion. The company expects 5% to 7% growth in adjusted claims this year.

Its adjusted earnings forecast represents 12% to 15% growth.

Write to Jon Kamp at jon.kamp@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : Express Scripts Holding Co, UnitedHealth Group Inc.
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EXPRESS SCRIPTS HOLDING CO
09/29 Deductibles For Employer Healthcare Plans Soar, Kaiser Family Foundation Repo..
09/28 EXPRESS SCRIPTS : employees to vote on union representation
09/17 EXPRESS SCRIPTS : Launches Inflammatory Conditions Care Value Program(SM), Makin..
09/17 EXPRESS SCRIPTS : Launches Diabetes Care Value Program℠, Guaranteeing More..
09/17 EXPRESS SCRIPTS : to Present at an Upcoming Conference
09/10 MASTERCARD : Tech training focus of Biden's LaunchCode visit
09/09 MASTERCARD : VP Biden touts technical training initiative at LaunchCode in St. L..
09/09 EXPRESS SCRIPTS : Launches Diabetes Care Value Program , Guaranteeing More Affor..
09/09 EXPRESS SCRIPTS HOLDING CO : Purcell Julie & Lefkowitz LLP Is Investigating Expr..
09/08 EXPRESS SCRIPTS : Launches Inflammatory Conditions Care Value Program(SM), Makin..
More news
Sector news : Drug Retailers - NEC
09/23DJRITE AID : Business Watch -- WSJ
09/22DJRITE AID : Same-Store Sales Fall Amid Generics Pressure
09/15 MCKESSON : German antitrust watchdog raids drugs distributors
09/14DJGoogle Acquisition Apigee's Revenue Climbs
09/14DJGoogle Acquisition Apigee's Revenue Climbs
More sector news : Drug Retailers - NEC
News from SeekingAlpha
09/22 Where Did All That EpiPen Money Go?
09/20 EXPRESS SCRIPTS : Avoid Business Cycle With Healthcare
09/19 WALGREENS BOOTS ALLIANCE : Buffett-Like Appeal
09/09 Where Will Express Scripts Go After It Hits The Easy Targets?
09/08 With Exec Reboot, Novo Concedes Diabetes Is A New Game
Advertisement
Financials ($)
Sales 2016 101 827 M
EBIT 2016 6 532 M
Net income 2016 2 908 M
Debt 2016 12 635 M
Yield 2016 -
P/E ratio 2016 15,49
P/E ratio 2017 14,02
EV / Sales 2016 0,56x
EV / Sales 2017 0,53x
Capitalization 44 701 M
More Financials
Chart EXPRESS SCRIPTS HOLDING CO
Duration : Period :
Express Scripts Holding Co Technical Analysis Chart | ESRX | US30219G1085 | 4-Traders
Full-screen chart
Technical analysis trends EXPRESS SCRIPTS H...
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 22
Average target price 82,5 $
Spread / Average Target 16%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Timothy C. Wentworth President, Chief Executive Officer & Director
George Paz Chairman
Christine Houston Senior Vice President-Operations
Eric R. Slusser Chief Financial Officer & Executive Vice President
Steven B. Miller Chief Medical Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
EXPRESS SCRIPTS HOLDIN..-18.85%44 701
CVS HEALTH CORP-7.76%96 151
WALGREENS BOOTS ALLIAN..-5.28%87 300
MCKESSON CORPORATION-15.52%37 606
CARDINAL HEALTH INC-12.33%25 039
AMERISOURCEBERGEN CORP..-19.78%19 793
More Results